Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about 1 billion
Slightly above 67% of VectivBio Holding's investor base is looking to short. The analysis of current outlook of investing in VectivBio Holding AG suggests that many traders are alarmed regarding VectivBio Holding's prospects. VectivBio Holding's investing sentiment can be driven by a variety of factors including economic data, VectivBio Holding's earnings reports, geopolitical events, and overall market trends.
VectivBio |
Ironwood Pharmaceuticals Inc. said Monday it has agreed to acquire Swiss biotech VectivBio Holding AG for 17 a share in cash, or a total of about 1...
Read at marketwatch.com
![]() |
VectivBio Holding Fundamental Analysis
We analyze VectivBio Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
VectivBio Holding is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
VectivBio Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VectivBio Holding stock to make a market-neutral strategy. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics with similar companies.
Peers
VectivBio Holding Related Equities
IMMX | Immix Biopharma | 2.63 | ||||
CNSP | Cns Pharmaceuticals | 1.89 | ||||
ZVSA | ZyVersa Therapeutics | 4.08 | ||||
ENVB | Enveric Biosciences | 5.49 | ||||
ZURA | Zura Bio | 5.56 | ||||
ELEV | Elevation Oncology | 7.84 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |